Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajeshwari R. Mehta

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cancer Prevention Research (Philadelphia, Pa.)|September 16, 2010
A 28-amino-acid peptide fragment of the cupredoxin azurin prevents carcinogen-induced mouse mammary lesionsRajeshwari R Mehta, Michael Hawthorne, Xinjian Peng, et al.
The Journal of Endocrinology|November 10, 2011
Regulation of CYP24 splicing by 1,25-dihydroxyvitamin D₃ in human colon cancer cellsXinjian Peng, Nishant Tiwari, Sarbani Roy, et al.
Cancer Journal (Sudbury, Mass.)|February 11, 2005
Designing a randomized phase I/II prostate cancer chemoprevention trial using 1alpha-hydroxy-24-ethyl-cholecalciferol, an analogue of vitamin D3S Packianathan, Rajendra G Mehta, Rajeshwari R Mehta, et al.
Clinical & Experimental Metastasis|May 7, 2013
Efficacy and mechanism of action of Deguelin in suppressing metastasis of 4T1 cellsRajeshwari R Mehta, Harshadadevi Katta, Amit Kalra, et al.
Molecular Cancer Therapeutics|October 8, 2009
A peptide fragment of azurin induces a p53-mediated cell cycle arrest in human breast cancer cellsTohru Yamada, Rajeshwari R Mehta, Fatima Lekmine, et al.
Cancer Research|January 17, 2009
Noncationic peptides obtained from azurin preferentially enter cancer cellsBrad N Taylor, Rajeshwari R Mehta, Tohru Yamada, et al.
Biology Open|May 6, 2020
A novel and cost-effective <i>ex vivo</i> orthotopic model for the study of human breast cancer in mouse mammary gland organ cultureAkash Gupta, Geetanjali Gupta, Rajeshwari R Mehta, et al.
Angiogenesis|June 14, 2011
A cell penetrating peptide derived from azurin inhibits angiogenesis and tumor growth by inhibiting phosphorylation of VEGFR-2, FAK and AktRajeshwari R Mehta, Tohru Yamada, Brad N Taylor, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cancer Prevention Research (Philadelphia, Pa.)|September 16, 2010
A 28-amino-acid peptide fragment of the cupredoxin azurin prevents carcinogen-induced mouse mammary lesionsRajeshwari R Mehta, Michael Hawthorne, Xinjian Peng, et al.
The Journal of Endocrinology|November 10, 2011
Regulation of CYP24 splicing by 1,25-dihydroxyvitamin D₃ in human colon cancer cellsXinjian Peng, Nishant Tiwari, Sarbani Roy, et al.
Cancer Journal (Sudbury, Mass.)|February 11, 2005
Designing a randomized phase I/II prostate cancer chemoprevention trial using 1alpha-hydroxy-24-ethyl-cholecalciferol, an analogue of vitamin D3S Packianathan, Rajendra G Mehta, Rajeshwari R Mehta, et al.
Clinical & Experimental Metastasis|May 7, 2013
Efficacy and mechanism of action of Deguelin in suppressing metastasis of 4T1 cellsRajeshwari R Mehta, Harshadadevi Katta, Amit Kalra, et al.
Molecular Cancer Therapeutics|October 8, 2009
A peptide fragment of azurin induces a p53-mediated cell cycle arrest in human breast cancer cellsTohru Yamada, Rajeshwari R Mehta, Fatima Lekmine, et al.
Cancer Research|January 17, 2009
Noncationic peptides obtained from azurin preferentially enter cancer cellsBrad N Taylor, Rajeshwari R Mehta, Tohru Yamada, et al.
Biology Open|May 6, 2020
A novel and cost-effective <i>ex vivo</i> orthotopic model for the study of human breast cancer in mouse mammary gland organ cultureAkash Gupta, Geetanjali Gupta, Rajeshwari R Mehta, et al.
Angiogenesis|June 14, 2011
A cell penetrating peptide derived from azurin inhibits angiogenesis and tumor growth by inhibiting phosphorylation of VEGFR-2, FAK and AktRajeshwari R Mehta, Tohru Yamada, Brad N Taylor, et al.
Pageof 2